Quarterly Result1 Aug 2025, 10:31 pm
HealthCare Global Enterprises Ltd Reports 417% Profit Growth in Q1FY26
AI Summary
HealthCare Global Enterprises Ltd (HCG), a leading provider of cancer care in India, announced its Q1FY26 financial results. The company reported a significant increase in revenue, adjusted EBITDA, and profit after tax. The growth was driven by strong performance across key geographies and improved cost efficiencies. However, the profit after tax was lower due to higher depreciation and interest expense from growth investments and acquisitions. HCG remains focused on clinical excellence and expanding capabilities in genomics and proteomics.
Key Highlights
- Revenue growth of 17% Y-o-Y, driven by strong performance across key geographies
- 20% Y-o-Y growth in Adj. EBITDA with 18.2% EBITDA margin
- 17% growth in OPD volumes and 62% in-patient bed occupancy
- 69% LINAC capacity utilization on a like for like basis
- Lower PAT on account of higher depreciation and interest expense